XML 56 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Stock Option Activity (Detail)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended
Nov. 03, 2018
USD ($)
$ / shares
shares
Options  
Outstanding - beginning of period | shares 2,190
Granted | shares 715
Exercised | shares (993) [1]
Outstanding- end of period | shares 1,912
Vested and expected to vest-end of period | shares 1,777
Exercisable-end of period | shares 171 [2]
Weighted-Average Exercise Price  
Outstanding-beginning of period | $ / shares $ 14.59
Granted | $ / shares 19.60
Exercised | $ / shares 15.60 [1]
Outstanding-end of period | $ / shares 16.75
Vested and expected to vest-end of period | $ / shares 16.69
Exercisable-end of period | $ / shares $ 14.92 [2]
Weighted-Average Remaining Contractual Term (In years)  
Outstanding-end of period 5 years 6 months
Vested and expected to vest-end of period 5 years 6 months
Exercisable-end of period 5 years 1 month 6 days [2]
Aggregate Intrinsic Value  
Outstanding-end of period | $ $ 10,507
Vested and expected to vest-end of period | $ 9,872
Exercisable-end of period | $ $ 1,256 [2]
[1] Options exercised during the 39 weeks ended November 3, 2018 had exercise prices ranging from $13.70 to $19.89.
[2] Options exercisable represent “in-the-money” vested options based upon the weighted-average exercise price of vested options compared to the Company’s stock price on November 3, 2018.